Items where Author is "Sorenson, Corinna"

Sorenson, Corinna and Drummond, Michael (2014) Improving medical device regulation: the United States and Europe in perspective. The Milbank Quarterly, 92 (1). pp. 114-150. ISSN 0887-378X

Sorenson, Corinna, Gusmano, M. and Oliver, Adam (2014) The politics of comparative effectiveness research: lessons from recent history. Journal of Health Politics, Policy and Law, 39 (1). pp. 139-170. ISSN 0361-6878

Sorenson, Corinna, Drummond, Michael and Wilkinson, Grahame (2013) Use of innovation payments to encourage the adoption of new medical technologies in the English NHS. Health Policy and Technology, 2 (3). pp. 168-173. ISSN 2211-8837

Sorenson, Corinna, Drummond, Michael and Bhuiyan Kahn, Beena (2013) Medical technology as a key driver of rising health expenditures: disentangling the relationship. Clinicoeconomics and Outcomes Research, 2013 (5). pp. 223-234. ISSN 1178-6981

Sorenson, Corinna, Drummond, Michael and Burns, Lawton R. (2013) Evolving reimbursement and pricing policies for devices in Europe and the United States should encourage greater value. Health Affairs, 32 (4). pp. 788-796. ISSN 0278-2715

Sorenson, Corinna, Drummond, Mike and Chalkidou, Kalipso (2012) Comparative effectiveness research: the experience of the National Institute for Health and Clinical Excellence. Journal of Clinical Oncology, 30 (34). pp. 4267-4274. ISSN 0732-183X

Sorenson, Corinna (2012) Valuing end-of-life care in the United States: the case of new cancer drugs. Health Economics, Policy and Law, 7 (04). pp. 411-430. ISSN 1744-1331

Sorenson, Corinna and Drummond, Mike (2012) The socioeconomic value of orthopaedic devices: evidence and methodological and challenges. Orthopaedic Research and Reviews, 2012 (4). pp. 87-96. ISSN 1179-1462

Towse, A, Drummond, Michael and Sorenson, Corinna (2012) Measuring value: pharmacoeconomics theory and practice. In: Danzon, Patricia M. and Nicholson, Sean, (eds.) Oxford Handbook on the Economics of the Biopharmaceutical Industry. Oxford University Press, Oxford, UK, pp. 394-437. ISBN 9780199742998 (Submitted)

Sorenson, Corinna and Chalkidou, K. (2012) Reflections on the evolution of health technology assessment in Europe. Health Economics, Policy and Law, 7 (1 (S)). pp. 25-45. ISSN 1744-1331

Sorenson, Corinna, Naci, Huseyin ORCID: 0000-0002-7192-5751, Cylus, Jonathan ORCID: 0000-0001-8269-1578 and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2011) Evidence of comparative efficacy should have a formal role in European drug approvals. British Medical Journal, 343 (7822). d4849-d4849. ISSN 0959-8138

Towse, Adrian, Drummond, Michael and Sorenson, Corinna (2011) Measuring value: pharmacoeconomics in theory and practice. Occasional paper (11/03). Office of Health Economics (London, England).

Sorenson, Corinna, Tarricone, Rosanna, Siebert, Markus and Drummond, Michael (2011) Applying health economics for policy decision making: how much do devices differ from drugs? Europace, 13. pp. 1154-1158. ISSN 1099-5129

Sorenson, Corinna and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2011) Medical technology procurement in Europe: a cross-country comparison of current practice and policy. Health Policy, 100 (1). pp. 43-50. ISSN 0168-8510

Barnett, Tony ORCID: 0000-0001-9399-9607 and Sorenson, Corinna (2011) Infectious disease surveillance in the United States and the United Kingdom: from public goods to the challenges of new technologies. Journal of Health Politics, Policy and Law, 36 (1). pp. 165-185. ISSN 0361-6878

Sorenson, Corinna (2010) Use of comparative effectiveness research in drug coverage and pricing decisions: a six-country comparison. Issue brief. The Commonwealth Fund.

Mladovsky, Philipa ORCID: 0000-0001-7761-6928 and Sorenson, Corinna (2010) Public financing of IVF: a review of policy rationales. Health Care Analysis, 18 (2). pp. 113-128. ISSN 1065-3058

Drummond, Michael and Sorenson, Corinna (2009) Use of pharmacoeconomics in drug reimbursement in Australia, Canada and the UK: what can we learn from international experience? In: Arnold, Renee J. G., (ed.) Pharmacoeconomics: From Theory to Practice. Drug discovery series. CRC Press, Florida, USA, pp. 175-196. ISBN 9781420084221

Drummond, Michael and Sorenson, Corinna (2009) Nasty or nice?: a perspective on the use of health technology assessment in the United Kingdom. Value in Health, 12 (S2). S8-S13. ISSN 1098-3015

Sorenson, Corinna and Oliver, Adam (2009) The limitations and challenges to the economic evaluation of health technologies. In: Costa-i-Font, Joan, Courbage, Christophe and McGuire, Alistair, (eds.) The Economics of New Health Technologies: Incentives, Organization, and Financing. Oxford University Press, Oxford, UK, pp. 205-216. ISBN 9780199550685

Oliver, Adam and Sorenson, Corinna (2009) The limits and challenges to the economic evaluation of health technologies. In: Costa-i-Font, Joan, Courbage, Christophe and McGuire, Alistair, (eds.) The Economics of New Health Technologies: Incentives, Organization, and Financing. Oxford University Press, Oxford, UK, pp. 205-218. ISBN 9780199550685

Drummond, Michael and Sorenson, Corinna (2009) Can NICE be nicer?: in a world of budget constraints there are no easy solutions. Value in Health, 12 (5). pp. 634-636. ISSN 1098-3015

Sorenson, Corinna, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Karamalis, M. (2009) HTA in Central and Eastern Europe: current status, challenges and opportunities. Journal of Medical Device Regulation, 6 (1). pp. 34-45. ISSN 1759-149X

Sorenson, Corinna (2009) Product development partnerships (PDPs) for neglected diseases: considerations on governance. Health Economics, Policy and Law, 4 (1). pp. 1-10. ISSN 1744-1331

Sorenson, Corinna and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2009) Topic 1: financing medical devices in France and the UK. . European Health Technology Institute on Socio-Economic Research.

Sorenson, Corinna (2009) The role of HTA in coverage and pricing decisions: a cross-country comparison. Euro Observer, 11 (1). pp. 1-4. ISSN 1020-7481

Sorenson, Corinna, Drummond, Michael, Kanavos, Panos ORCID: 0000-0001-9518-3089 and McGuire, Alistair ORCID: 0000-0002-5367-9841 (2008) Does the work of the National Institute for Health and Clinical Excellence (NICE) have any relevance for the United States? ISPOR Connections, 14 (4). pp. 7-9. ISSN 1538-5108

Sorenson, Corinna (2008) Financing of medical technologies in Europe: the case of the UK and France. . The European Health Technology Institute for Socio-Economic Research, London School of Economics, London, UK.

Oliver, Adam ORCID: 0000-0003-3880-9350 and Sorenson, Corinna (2008) Importance of preference reversals in the valuation of health and healthcare. Expert Review of Pharmacoeconomics and Outcomes Research, 8 (2). pp. 95-99. ISSN 1473-7167

Sorenson, Corinna, Drummond, Michael, Kanavos, Panos ORCID: 0000-0001-9518-3089 and McGuire, Alistair ORCID: 0000-0002-5367-9841 (2008) National Institute for Health and Clinical Excellence (NICE). How does it work and what are the implications for the U.S? . National Pharmaceutical Council, Virginia, USA.

Sorenson, Corinna, Drummond, Michael, Kristensen, Finn Børlum and Busse, Reinhard (2008) How can the impact of health technology assessments be enhanced? Health systems and policy analysis. World Health Organization, Copenhagen, Denmark.

Oliver, Adam and Sorenson, Corinna (2008) On equity in the English National Health Service. Harvard Health Policy Review, 8 (2). pp. 100-107. ISSN 1533-774X

Sorenson, Corinna (2008) The procurement landscape for medical devices in England: recent developments and applications to wound care. Eurohealth, 14 (3). pp. 4-6. ISSN 1356-1030

Martin, Greg, Sorenson, Corinna and Faunce, Thomas (2007) Balancing intellectual monopoly privileges and the need for essential medicines. Globalization and Health, 3 (4). ISSN 1744-8603

Sorenson, Corinna and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2007) Measuring quality and standards of long-term care for older people. Research note. European Commission, Brussels, Belgium.

Sorenson, Corinna, Drummond, Michael and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2007) Ensuring value for money in health care: The role of HTA in the European Union. In: Financing sustainable healthcare in Europe: New approaches for new outcomes, 2007-02-07 - 2007-02-08, Helsinki, Finland, FIN.

Allin, Sara, Masseria, Cristina, Sorenson, Corinna, Papanicolas, Irene ORCID: 0000-0002-8000-3185 and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2007) Measuring inequalities in access to health care: a review of the indices? . European Commission, Brussels, Belgium.

Sorenson, Corinna (2007) Quality measurement and assurance of long-term care for older people. Euro Observer, 9 (2). pp. 1-4. ISSN 1020-7481

Masseria, Cristina, Allin, Sara, Sorenson, Corinna, Papanicolas, Irene ORCID: 0000-0002-8000-3185 and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2007) What are the methodological issues related to measuring health and drawing comparisons across countries? . European Commission, Brussels, Belgium.

Sorenson, Corinna and Mladovsky, Philipa ORCID: 0000-0001-7761-6928 (2006) Assisted reproduction technologies in Europe: an overview. Research note. European Commission, Brussels, Belgium.

Sorenson, Corinna (2006) ART in the European Union. Euro Observer, 8 (4). pp. 1-8. ISSN 1020-7481

Sorenson, Corinna and Mladovsky, Philipa ORCID: 0000-0001-7761-6928 (2006) ART treatment in the EU: NICE guidelines for infertility treatment. Euro Observer, 8 (4). p. 8. ISSN 1020-7481

Sorenson, Corinna (2006) Children's lifestyles in Europe. Eurohealth, 12 (2). pp. 21-22. ISSN 1356-1030

Sorenson, Corinna (2006) IVF/ART funding and reimbursement. Euro Observer, 8 (4). pp. 6-8. ISSN 1020-7481

Sorenson, Corinna and Mladovsky, Philipa ORCID: 0000-0001-7761-6928 (2006) NICE guidelines for fertility treatment. Euro Observer, 8 (4). p. 8. ISSN 1020-7481

Martin, Greg and Sorenson, Corinna (2006) TRIPS, trade, and tablets for all: balancing intellectual property and the demand for medicine. In: The Commonwealth Health Ministers Reference Book. Henley Media Group Ltd, London, UK, pp. 53-57. ISBN 9780954657277

Sorenson, Corinna and Gemmen, Eric (2004) Development of a health economic model to demonstrate the costs and morbidity implications of an investigational obesity drug: technical report prepared for a US pharmaceutical company. . The Lewin Group, Falls Church, Virginia, USA.

Sorenson, Corinna and Robboy, E. (2004) An innovative approach to post-market surveillance of emerging adverse events. . US Food and Drug Administration, Rockville, Maryland, USA.